| Effects of telmisartan and amlodipine in combination on ambulatory blood pressure in stages 1-2 hypertension. | |
| | |
MedLine Citation:
|
PMID: 20613496 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
BACKGROUND: Evaluation of combination therapy with antihypertensive agents by clinic blood pressure (BP) measurements may yield results that differ from out-of-office BP readings. This is of clinical relevance because out-of-office BP values are of prognostic importance. We studied the effects of combining telmisartan and amlodipine on ambulatory BP in patients with stages 1-2 hypertension. METHODS: We conducted an 8-week, placebo-controlled, double-blind, 4x4 factorial design trial in which 562 patients with clinic diastolic BP at least 95 and 119 mmHg or less were randomized to receive telmisartan (0, 20, 40, or 80 mg) and/or amlodipine (0, 2.5, 5, or 10 mg). Ambulatory BP monitoring was performed at baseline and after 8 weeks of treatment; the end points of interest were the changes from baseline in 24-h systolic and diastolic BP. Secondary end points included the proportion of responders (> or =10 mmHg BP reduction from baseline and/or <130/80 mean 24-h BP) and controlled patients (<130/80 mmHg mean 24-h BP). RESULTS: Combination therapies of telmisartan and amlodipine lowered 24-h BP to a larger extent than the corresponding monotherapies at all doses. Mean reductions from baseline in 24-h BP for the combination of the highest doses of telmisartan (80 mg) and amlodipine (10 mg) were -22.4/-14.6 versus -11.9/-6.9 mmHg for amlodipine (10 mg) and -11.0/-6.9 mmHg for telmisartan (80 mg) (P<0.0001 for each comparison). In addition, BP response and control rates (24-h BP <130/80 mmHg) were significantly higher with the combination therapy versus the monotherapy groups. CONCLUSION: These findings show that telmisartan and amlodipine in combination provide substantial 24-h BP efficacy that is superior to either monotherapy in patients with stages 1 and 2 hypertension. |
| | |
Authors:
|
William B White; Thomas W Littlejohn; Claudio R Majul; Willie Oigman; Rafael Olvera; Mary Seeber; Helmut Schumacher; Giuseppe Mancia |
Related Documents
:
|
16647616 - A comparison of home measurement and ambulatory monitoring of blood pressure in the adj... 15096906 - Comparison of the effects on 24-h ambulatory blood pressure of valsartan and amlodipine... 19779486 - Uncontrolled hypertension based on morning and evening home blood pressure measurements... 20182456 - Achieving blood pressure goal: initial therapy with valsartan/hydrochlorothiazide combi... 6992636 - Solar-powered ventilator alarm. 7097556 - Effects of diltiazem on total cardiac output distribution in conscious rats. |
Publication Detail:
|
Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't |
Journal Detail:
|
Title: Blood pressure monitoring Volume: 15 ISSN: 1473-5725 ISO Abbreviation: Blood Press Monit Publication Date: 2010 Aug |
Date Detail:
|
Created Date: 2010-07-14 Completed Date: 2010-11-10 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 9606438 Medline TA: Blood Press Monit Country: England |
Other Details:
|
Languages: eng Pagination: 205-12 Citation Subset: IM |
Affiliation:
|
Pat and Jim Calhoun Cardiology Center, University of Connecticut School of Medicine, Farmington, 06030, USA. wwhite@nso1.uchc.edu |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adult Aged Aged, 80 and over Amlodipine / administration & dosage, therapeutic use* Angiotensin II Type 1 Receptor Blockers / administration & dosage Antihypertensive Agents / administration & dosage Benzimidazoles / administration & dosage, therapeutic use* Benzoates / administration & dosage, therapeutic use* Blood Pressure / drug effects Blood Pressure Monitoring, Ambulatory Double-Blind Method Drug Therapy, Combination Female Humans Hypertension / drug therapy* Male Middle Aged Treatment Outcome |
| Chemical | |
Reg. No./Substance:
|
0/Angiotensin II Type 1 Receptor Blockers; 0/Antihypertensive Agents; 0/Benzimidazoles; 0/Benzoates; 144701-48-4/telmisartan; 88150-42-9/Amlodipine |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: SSR504734, a glycine transporter-1 inhibitor, attenuates acquisition and expression of contextual co...
Next Document: Soluble transforming growth factor-beta1 receptor II might inhibit transforming growth factor-beta-i...